20 Coronary Heart Disease, Angina, MI and Embolism Flashcards
Q: How does coronary artery disease present? (7) Main?
A: o Sudden cardiac death ***
o Acute coronary syndrome
– Acute myocardial infarction
– Unstable angina
o Stable angina pectoris (chest pain or discomfort due to coronary heart disease)
o Heart failure
o Arrhythmia (as a result of heart muscle scarring eg heart attack)
Q: Name 4 determinants of risk factors for CHD. Name 4 of the risks can that lead to CHD. What percentage of CHD cases are down to these?
A: Tobacco use,
physical inactivity,
harmful use of alcohol,
unhealthy diet
accounts results in:
– Hypertension
– Obesity
– Diabetes mellitus
– Hyperlipdaemia
~80%
Q: CVD is the leading cause of death in? (3) Common CVD?
A: -developed and low/medium income countries
- <70yr
- women worldwide
CHD
Q: What is Myocardial Ischaemia? 2 broad categories? Describe in terms of coronary arteries. When do they each tend to occur?
A: o Mismatch between myocardial oxygen
supply and demand
o Primary reduction in blood flow- eg coronary arteries are blocked
=> occurs in stable angina
o Inability to increase blood flow to match
increased metabolic demand- eg coronary arteries have narrowed
=> tends to occur in those with acute heart attacks
Q: Graphs to show functional anatomy of coronary circulation- pressure changes:
- aorta to capillaries
- response to flow dependant dilation
- response to changes in intravascular pressure
- response to metabolites
A: REFER
X = conductive arteries -> prearterioles -> arterioles
Q: What are the 2 components of coronary arteries? How does the structure of arteries change as they enter the heart? (2) How is resistance divided? (2)
A: -epicardial component
-intramyocardial component
The big conduit arteries divide into smaller arterioles and these then divide into the myocardium
Overall coronary resistance is divided 50% in the large arteries and 50% in the smaller arteries and capillaries
Q: What is the role of coronary circulation? (3)
A: 1. To make sure that over a wide range of perfusion pressures, flow remains constant - AUTOREGULATION
- To make sure that coronary blood flow matches myocardial demand
- deliver oxygen and nutrients and remove toxic waste products
Q: What can occur to coronary circulation to change it? (2) 3 examples.
A: -arterioles can change
-capillary resistance can change
- Arterioles dilate in response to changes in blood pressure
- they are subject to vasoconstriction and vasodilation due to the autonomic nervous system
- Changes in capillary resistance is responsive to myocardial metabolic stimuli
Q: What are epicardial coronary arteries? dependant on?
A: are mainly conductance vessels - dependent on arterial blood pressure
Q: What is the effect of epicardial stenosis on resting coronary resistance? How is this compensated? result?
A: (Usually the resistance in the smaller arteries in the myocardium and the larger arteries outside the myocardium is equal)
If you have stenosis in the epicardial compartment - the resistance in the epicardial component INCREASES
This can be compensated to a degree by an increase in the diameter of the intramyocardial resistance vessels - thus decreasing the resistance in the intramyocardial component to maintain flow
Q: Graph to show how coronary blood flow changes with percent stenosis. (2)
A: As we increase the stenosis, the resting blood flow remains unchanged because of the response of the intramyocardial arterioles
After around 70% stenosis, the coronary blood flow decreases rapidly
Q: What can trigger a sympathetic stimulus? leads to? (2) result?
A: Lots of things can trigger a sympathetic stimulus which leads to an increase in heart rate and blood pressure hence leading to an increase in coronary flow
Q: What is coronary flow reserve? Ability of? Draw a graph showing this against percentage diameter stenosis. What does this graph show?
A: ratio of resting blood flow: blood flow achieved under maximal stress
ability of the coronary circulation to adapt to an increasing demand in the face of an increasing epicardial coronary stenosis
- This ratio is on the y axis on the right : in 3 to 5 range
- REFER
once reach 50 severity= ability to increase blood flow in face of stenosis reduces => impairment of coronary flow reserve
Q: Draw a graph for percentage stenosis against coronary vasodilator reserve. What does it show? (2) Where does this happen?
A: REFER
- we’re looking at the ability of the coronary circulation to dilate in the face of a narrowing coronary artery
- you find that the ability to maintain the requisite amount of flow needed under stressful conditions starts to become impaired around 50% stenosis
This is what happens in people with stable coronary disease
Q: How does the stenosis severity threshold differ between changes in resting blood flow and the expression of exertional symptoms?
A: threshold at which peak ability to increase flow under high demand situations is at a lower level of stenosis severity than stenosis severity that was required to reduce resting flow = people can present with exertional symptoms at a lower threshold of stenosis severity than that required to reduce resting blood flow
Q: Explain the ischaemic cascade. (7)
A: 1. heart in normal condition where blood flow is matched to demand
- as stenosis gets more and more severe-> get situations of mismatch
- begets impairment of perfusion
- heart can’t pump well if perfusion is abnormal/ insufficient
- leads primarily to change in diastolic function, relaxation of the heart
- when relaxation function is impaired, systolic function (contractile) becomes impaired
- after that-> see changes on resting/surface ECG electrocardiogram
- last feature patients experience as part of cascade is symptom of angina pectoris
Q: What is the clinical diagnosis of angina pectoris based on? It is? (2) Provoked by? (3) Relieved by?
A: Clinical diagnosis based on the constellation of symptoms
It is a tight feeling in the chest which can diffuse across the jaw, shoulders, back or arms
It can be provoked by physical exertion, emotional stress or anxiety
It can be relieved by rest
Q: What does the investigation of stable CAD achieve? (2-1,3) What determines what tests are run?
A: stable coronary artery disease
To confirm the clinical diagnosis
-Demonstrate myocardial ischaemia
To assess risk of future adverse cardiovascular events
- Burden of myocardial ischaemia
- Anatomic severity of coronary artery disease
- LV function
choice of test is dependant on clinical probability of CHD
Q: How can the tests for CHD (and CAD) be divided? (2) What does each do? How are they further divided?
A: functional and anatomical
Functional - demonstrate that there is an imbalance between supply and demand - look for ischaemia
Anatomical - look at anatomical severity of the narrowing within the artery then make an inference about how it is compromising flow
- invasive
- non invasive
Q: CHD tests (stable CAD). How do you view stenoses?
How do you determine the degree to which flow is impaired?
What do non invasive tests involve? (3)
Imaging techniques include? (3)
A: A catheter can be inserted into the radial or femoral artery and moved along to the left main coronary artery to identify the stenoses that you see
Computational fluid dynamics can be used to determine the degree to which flow is impaired // radioactive tracers and scans
Non-invasive tests can involve giving stressing agents to create situations of increased oxygen demand
You can give inotropic agents (beta agonists), vasodilators or get the patient to exercise
Imaging techniques include: echocardiography, MRI or nuclear perfusion imaging
Q: What are the 3 treatment strategies for Stable CAD (CHD)?
A: o Prevent atherosclerosis progression and risk of
death/MI
o Reduce myocardial oxygen demand
o Improve blood supply
Q: Stable CAD treatment (CHD). How do you prevent atherosclerosis progression and risk of death/MI? (3)
A: – Education
– Lifestyle modification
– Aspirin, statins, ACE inhibitors = main drugs
Q: Stable CAD treatment (CHD). How do you reduce myocardial oxygen demand? (3)
A: – HR (b blockers, Ca antagonists, If blockers)
– wall stress (ACE inhibitors, Ca antagonists)
– Metabolic modifiers